Literature DB >> 2452511

Comparative morphology and tumourigenicity of human hepatocellular carcinoma cell lines in athymic rats and mice.

D Shouval1, L Schuger, I S Levij, L M Reid, Z Neeman, D A Shafritz.   

Abstract

Four human hepatoma cell lines PLC/PRF/5, Hep G2, Sk-Hep 1 and Mahlavu were inoculated subcutaneously into athymic Balb/c nude mice and N/NIH outbred nude rats, producing well encapsulated tumours. The 4 hepatoma tumour types in the athymic rodents differ morphologically. PLC/PRF/5 and Hep G2 cells are well differentiated polygonal cells which resemble normal hepatocytes. Tumour arrangement is characterized by solid masses and trabeculae while stromal support is minimal. In contrast, Mahlavu and Sk-Hep 1 tumours have a sarcomatous appearance and consist of spindle shaped cells arranged in solid masses with a rich stromal support. Tumourigenicity of hepatoma cells in the athymic rodents was dependent on injected cell type, inoculation density, relative immunocompetence of the host and the species of animals used. In nude mice, Sk-Hep 1 cells were the most tumourigenic, while Hep G2 cells were tumourigenic only at very high inoculation densities. In nude rats, which were more resistant to tumour formation, PLC/PRF/5 cells were the most tumourigenic. Pre-treatment of athymic mice and rats with total body irradiation resulted in enhanced tumourigenicity for all hepatoma cell lines tested. This was manifested as increased "take" rates, a decreased latency from tumour cell injection to tumour detection, increased tumour weight, and for PLC/PRF/5 cells an increased invasiveness to adjacent body cavities. Furthermore, following irradiation, the minimal number of injected cells required to produce subcutaneous tumours was markedly reduced in both animal species, regardless of tumour cell type. The protocols described enable the reproducible growth of human hepatoma tumours in athymic rodents.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452511     DOI: 10.1007/bf00844296

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  30 in total

1.  Absence of HeLa cell contamination in 169 cell lines derived from human tumors.

Authors:  J Fogh; W C Wright; J D Loveless
Journal:  J Natl Cancer Inst       Date:  1977-02       Impact factor: 13.506

2.  Human hepatoma-associated cell surface antigen: identification and characterization by means of monoclonal antibodies.

Authors:  D Shouval; D Eilat; R I Carlson; R Adler; N Livni; J R Wands
Journal:  Hepatology       Date:  1985 May-Jun       Impact factor: 17.425

3.  In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice.

Authors:  S Habu; H Fukui; K Shimamura; M Kasai; Y Nagai; K Okumura; N Tamaoki
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

4.  Influence of anti-mouse interferon serum on the growth and metastasis of tumor cells persistently infected with virus and of human prostatic tumors in athymic nude mice.

Authors:  L M Reid; N Minato; I Gresser; J Holland; A Kadish; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

5.  A human hepatoma cell line (PCL/PRF/5) produces lung metastases and secretes HBsAg in nude mice.

Authors:  F R Sattler; S Paolucci; J W Kreider; R L Ladda
Journal:  Eur J Cancer Clin Oncol       Date:  1982-04

6.  Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus.

Authors:  D Shouval; B Rager-Zisman; P Quan; D A Shafritz; B R Bloom; L M Reid
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

7.  Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen.

Authors:  B B Knowles; C C Howe; D P Aden
Journal:  Science       Date:  1980-07-25       Impact factor: 47.728

8.  Heterotransplantation of human cancers into nude mice: a model system for human cancer chemotherapy.

Authors:  B C Giovanella; J S Stehlin; L J Williams; S S Lee; R C Shepard
Journal:  Cancer       Date:  1978-11       Impact factor: 6.860

9.  Establishment of a cell line (HCC-M) from a human hepatocellular carcinoma.

Authors:  T Watanabe; T Morizane; K Tsuchimoto; Y Inagaki; Y Munakata; T Nakamura; N Kumagai; M Tsuchiya
Journal:  Int J Cancer       Date:  1983-08-15       Impact factor: 7.396

10.  Hepatitis B surface antigen produced by a human hepatoma cell line.

Authors:  G M MacNab; J J Alexander; G Lecatsas; E M Bey; J M Urbanowicz
Journal:  Br J Cancer       Date:  1976-11       Impact factor: 7.640

View more
  7 in total

1.  SK HEP-1: a human cell line of endothelial origin.

Authors:  S C Heffelfinger; H H Hawkins; J Barrish; L Taylor; G J Darlington
Journal:  In Vitro Cell Dev Biol       Date:  1992-02

2.  Evaluation of the potent anti-hepatitis B virus agent (-) cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo model.

Authors:  L D Condreay; R W Jansen; T F Powdrill; L C Johnson; D W Selleseth; M T Paff; S M Daluge; G R Painter; P A Furman; M N Ellis
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

3.  FXR controls the tumor suppressor NDRG2 and FXR agonists reduce liver tumor growth and metastasis in an orthotopic mouse xenograft model.

Authors:  Ulrich Deuschle; Julia Schüler; Andreas Schulz; Thomas Schlüter; Olaf Kinzel; Ulrich Abel; Claus Kremoser
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

4.  Piper and Vismia species from Colombian Amazonia differentially affect cell proliferation of hepatocarcinoma cells.

Authors:  Leandro J Lizcano; Maite Siles; Jenifer Trepiana; M Luisa Hernández; Rosaura Navarro; M Begoña Ruiz-Larrea; José Ignacio Ruiz-Sanz
Journal:  Nutrients       Date:  2014-12-30       Impact factor: 5.717

5.  Reliable establishment of human sarcoma xenografts in the nude rat.

Authors:  P T Tinkey; M Milas; R E Pollock
Journal:  Sarcoma       Date:  1999

6.  Design and development of a robotized system coupled to µCT imaging for intratumoral drug evaluation in a HCC mouse model.

Authors:  Gaétan Bour; Fernand Martel; Laurent Goffin; Bernard Bayle; Jacques Gangloff; Marc Aprahamian; Jacques Marescaux; Jean-Marc Egly
Journal:  PLoS One       Date:  2014-09-09       Impact factor: 3.240

7.  Multimodal imaging of a humanized orthotopic model of hepatocellular carcinoma in immunodeficient mice.

Authors:  Tao Wu; Emilie Heuillard; Véronique Lindner; Ghina Bou About; Mihaela Ignat; Jean-Philippe Dillenseger; Nicolas Anton; Eugénie Dalimier; Francine Gossé; Gael Fouré; Franck Blindauer; Céline Giraudeau; Hussein El-Saghire; Mourad Bouhadjar; Cynthia Calligaro; Tania Sorg; Philippe Choquet; Thierry Vandamme; Christophe Ferrand; Jacques Marescaux; Thomas F Baumert; Michele Diana; Patrick Pessaux; Eric Robinet
Journal:  Sci Rep       Date:  2016-10-14       Impact factor: 4.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.